Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ribbon Communications Inc.RBBN · Entity 5785 | EVP, Chief Legal Officer | June 15, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ribbon Communications Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restructed Stock Unites (RSUs)SEC Table II · derivative / convertible security | Direct | 162,500 |
Reported balance
After 2026-06-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-15 · Grant · Acquired 162,500 · Balance 162,500 F1: The RSUs and PSUs convert to Common Stock on a one-for-one basis. F2: The RSUs vest as to one-third on June 15, 2027; the remaining two-thirds of the RSUs will vest in four equal semi-annual installments thereafter through June 15, 2029. |
| Performance-Based RSUs (PSUs)SEC Table II · derivative / convertible security | Direct | 97,500 |
Reported balance
After 2026-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-15 · Grant · Acquired 97,500 · Balance 97,500 F1: The RSUs and PSUs convert to Common Stock on a one-for-one basis. F3: The number of PSUs earned and issuable upon vesting will be determined based on goals (set by the Compensation Committee of the Board of Directors (the "Compensation Committee") on an annual basis) for each of the three fiscal years prior to the vesting date. The aggregate number of shares issued may range from zero shares to 100% of the target number of shares reported in columns 5, 7 and 9 of Table II. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance. These PSUs will vest on April 15, 2029. |
| PSUsSEC Table II · derivative / convertible security | Direct | 65,000 |
Reported balance
After 2026-06-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-15 · Grant · Acquired 65,000 · Balance 65,000 F1: The RSUs and PSUs convert to Common Stock on a one-for-one basis. F4: The number of PSUs earned and issuable upon vesting will be determined based on the Issuer's total shareholder return (TSR) compared to pre-established relative TSR goals, based on the TSR of a peer index of companies (set by the Compensation Committee at the time of grant) over the three fiscal years ending prior to the vesting date. The aggregate number of shares issued may range from zero shares to 125% of the target number of shares reported in columns 5, 7 and 9 of Table II. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance. These PSUs will vest on April 15, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSUs and PSUs convert to Common Stock on a one-for-one basis.
F2: The RSUs vest as to one-third on June 15, 2027; the remaining two-thirds of the RSUs will vest in four equal semi-annual installments thereafter through June 15, 2029.
F3: The number of PSUs earned and issuable upon vesting will be determined based on goals (set by the Compensation Committee of the Board of Directors (the "Compensation Committee") on an annual basis) for each of the three fiscal years prior to the vesting date. The aggregate number of shares issued may range from zero shares to 100% of the target number of shares reported in columns 5, 7 and 9 of Table II. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance. These PSUs will vest on April 15, 2029.
F4: The number of PSUs earned and issuable upon vesting will be determined based on the Issuer's total shareholder return (TSR) compared to pre-established relative TSR goals, based on the TSR of a peer index of companies (set by the Compensation Committee at the time of grant) over the three fiscal years ending prior to the vesting date. The aggregate number of shares issued may range from zero shares to 125% of the target number of shares reported in columns 5, 7 and 9 of Table II. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance. These PSUs will vest on April 15, 2029.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARRIS International plc
Report date April 04, 2019 · Filed April 09, 2019
Section 16 reporting ended · disclosed 2019-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 1
1 source rowRow 1 · 2019-04-04 · Disposition to issuer · Disposed 21,712 · Balance 0 F1: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-04 · Disposition to issuer · Disposed 15,130 · Balance 0 F2: At the Effective Time, this performance-based restricted stock unit grant, which provided for vesting between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period, was deemed to have satisfied its performance-based vesting conditions at the target level, and was cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of Ordinary Shares subject to such performance-based restricted stock units. F3: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-04-04 · Disposition to issuer · Disposed 13,110 · Balance 0 F2: At the Effective Time, this performance-based restricted stock unit grant, which provided for vesting between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period, was deemed to have satisfied its performance-based vesting conditions at the target level, and was cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of Ordinary Shares subject to such performance-based restricted stock units. F3: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2020-07-07 | Direct | 2,862 |
Reported balance
After 2019-04-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-04-04 · Disposition to issuer · Disposed 921 · Balance 2,862 F4: At the Effective Time, 24.35% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2020-07-07 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-04-04 · Disposition to issuer · Disposed 2,862 · Balance 0 F5: At the Effective Time, 75.65% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were assumed and converted into restricted stock units denominated in shares of CommScope common stock equal to (i) the number of restricted stock units being so converted multiplied by (ii) an exchange ratio, (A) the numerator of which is $31.75 and (B) the denominator of which is the volume-weighted average price per share of CommScope's Common Stock for the 20 trading days prior to the Effective Time of $22.0581, but otherwise remained subject to the original terms and vesting schedule associated with such assumed restricted stock unit |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-04-04 · Disposition to issuer · Disposed 24,698 · Balance 0 F6: At the Effective Time, this performance-based restricted stock unit grant, which provided for vesting between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period, was deemed to have satisfied its performance-based vesting conditions at a level that results in performance vesting at 150% of the target level, and was cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of Ordinary Shares subject to such performance-based restricted stock units. F3: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-03-29 | Direct | 2,480 |
Reported balance
After 2019-04-04 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-04-04 · Disposition to issuer · Disposed 798 · Balance 2,480 F4: At the Effective Time, 24.35% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-03-29 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-04-04 · Disposition to issuer · Disposed 2,480 · Balance 0 F5: At the Effective Time, 75.65% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were assumed and converted into restricted stock units denominated in shares of CommScope common stock equal to (i) the number of restricted stock units being so converted multiplied by (ii) an exchange ratio, (A) the numerator of which is $31.75 and (B) the denominator of which is the volume-weighted average price per share of CommScope's Common Stock for the 20 trading days prior to the Effective Time of $22.0581, but otherwise remained subject to the original terms and vesting schedule associated with such assumed restricted stock unit |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2022-03-30 | Direct | 6,569 |
Reported balance
After 2019-04-04 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-04-04 · Disposition to issuer · Disposed 2,115 · Balance 6,569 F4: At the Effective Time, 24.35% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted. |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2022-03-30 | Direct | 0 |
Reported balance
After 2019-04-04 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-04-04 · Disposition to issuer · Disposed 6,569 · Balance 0 F5: At the Effective Time, 75.65% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were assumed and converted into restricted stock units denominated in shares of CommScope common stock equal to (i) the number of restricted stock units being so converted multiplied by (ii) an exchange ratio, (A) the numerator of which is $31.75 and (B) the denominator of which is the volume-weighted average price per share of CommScope's Common Stock for the 20 trading days prior to the Effective Time of $22.0581, but otherwise remained subject to the original terms and vesting schedule associated with such assumed restricted stock unit |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Bid Conduct Agreement (the "Acquisition Agreement") between ARRIS International plc ("ARRIS") and CommScope Holding Company, Inc. ("CommScope"), CommScope agreed to acquire all of the issued and to be issued Ordinary Shares of ARRIS (the "Acquisition") for $31.75 per Ordinary Share by means of a court-sanctioned scheme of arrangement (the "Scheme"). On April 4, 2019, at the effective time of the Scheme (the "Effective Time"), each Ordinary Share then outstanding was automatically transferred from ARRIS shareholders in accordance with the Scheme and the Acquisition Agreement to CommScope, and the ARRIS shareholders ceased to have any rights with respect to their Ordinary Shares, except their right to receive $31.75 per Ordinary Share. This represents shares disposed of upon consummation of the Acquisition.
F2: At the Effective Time, this performance-based restricted stock unit grant, which provided for vesting between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period, was deemed to have satisfied its performance-based vesting conditions at the target level, and was cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of Ordinary Shares subject to such performance-based restricted stock units.
F3: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule.
F4: At the Effective Time, 24.35% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of restricted stock units being so cancelled and converted.
F5: At the Effective Time, 75.65% of the Ordinary Shares subject to this restricted stock unit grant, which provided for vesting in four equal annual installments beginning one year from the date of grant, were assumed and converted into restricted stock units denominated in shares of CommScope common stock equal to (i) the number of restricted stock units being so converted multiplied by (ii) an exchange ratio, (A) the numerator of which is $31.75 and (B) the denominator of which is the volume-weighted average price per share of CommScope's Common Stock for the 20 trading days prior to the Effective Time of $22.0581, but otherwise remained subject to the original terms and vesting schedule associated with such assumed restricted stock unit
F6: At the Effective Time, this performance-based restricted stock unit grant, which provided for vesting between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period, was deemed to have satisfied its performance-based vesting conditions at a level that results in performance vesting at 150% of the target level, and was cancelled and converted into the right to receive cash equal to $31.75 multiplied by the number of Ordinary Shares subject to such performance-based restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2018 Filed Jul 11, 2018 00:00 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 2,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023052 · form4.xml · nonDerivative · entry 1 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:00 UTC | ARRIS International plc ARRS · Entity 158436 | SaleOrdinary Shares | 1,400 | $27.37 | $38,311.00 |
DisclosureSEC source: 0001415889-18-000710 · form4-05112018_050502.xml · nonDerivative · entry 1 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,534 Read SEC document |
| March 30, 2018 Filed Apr 6, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | GrantRestricted Shares (T) 180330 · Derivative | 16,465 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-18-000586 · form4-04052018_090440.xml · derivative · entry 3 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,465 Underlying: Ordinary Shares · 16,465 shares Expires not disclosed F3 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F2 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 30, 2018 Filed Apr 6, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | GrantRestricted Shares (P) 180330 · Derivative | 32,930 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-18-000586 · form4-04052018_090440.xml · derivative · entry 2 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,930 Underlying: Ordinary Shares · 32,930 shares Expires not disclosed F1 · security: Represents a restricted stock unit grant that is performance-based and can vest between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period. Amount shown reflects maximum vesting of the award at the 200% level. F2 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | Tax withholdingRestricted Shares (T) 170329 · Derivative | 995 | $26.27 Strike: $0.00 | $26,138.65 |
DisclosureSEC source: 0001415889-18-000520 · form4-04022018_090435.xml · derivative · entry 6 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,833 Underlying: Ordinary Shares · 10,828 shares Expires not disclosed F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F4 · shares: Represents shares cash cancelled to cover payroll tax liability on vesting of previously granted restricted stock units. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | Tax withholdingRestricted Shares (T) 150330 · Derivative | 914 | $26.27 Strike: $0.00 | $24,010.78 |
DisclosureSEC source: 0001415889-18-000520 · form4-04022018_090435.xml · derivative · entry 4 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 Underlying: Ordinary Shares · 3,924 shares Expires not disclosed F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F4 · shares: Represents shares cash cancelled to cover payroll tax liability on vesting of previously granted restricted stock units. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionRestricted Shares (T) 150330 · Derivative | 2,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-18-000520 · form4-04022018_090435.xml · derivative · entry 3 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,924 Underlying: Ordinary Shares · 8,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 2,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-18-000520 · form4-04022018_090435.xml · nonDerivative · entry 2 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. Read SEC document |
| March 22, 2018 Filed Apr 3, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionRestricted Shares (T) 170329 · Derivative | 2,282 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-18-000520 · form4-04022018_090435.xml · derivative · entry 5 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,828 Underlying: Ordinary Shares · 13,110 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 22, 2018 Filed Apr 3, 2018 01:00 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 2,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-18-000520 · form4-04022018_090435.xml · nonDerivative · entry 1 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:35 UTC | ARRIS International plc ARRS · Entity 158436 | SaleOrdinary Shares | 1,250 | $29.26 | $36,568.75 |
DisclosureSEC source: 0001415889-17-001856 · form4-11222017_041101.xml · nonDerivative · entry 1 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,556 Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:31 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionRestricted Shares (T) 160707 · Derivative | 2,520 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001182 · form4-07112017_080711.xml · derivative · entry 3 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,348 Underlying: Ordinary Shares · 13,868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. F4 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:31 UTC | ARRIS International plc ARRS · Entity 158436 | Tax withholdingRestricted Shares (T) 160707 · Derivative | 1,262 | $27.46 Strike: $0.00 | $34,654.52 |
DisclosureSEC source: 0001415889-17-001182 · form4-07112017_080711.xml · derivative · entry 2 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,868 Underlying: Ordinary Shares · 15,130 shares Expires not disclosed F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F3 · shares: Represents shares cash cancelled to cover payroll tax liability on vesting of previously granted restricted stock units. F4 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:31 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001182 · form4-07112017_080711.xml · nonDerivative · entry 1 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to ordinary shares. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 21:50 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionRestricted Shares (T) 150330 · Derivative | 2,030 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000554 · form4-03312017_020345.xml · derivative · entry 5 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,020 Underlying: Ordinary Shares · 8,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to common stock. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 21:50 UTC | ARRIS International plc ARRS · Entity 158436 | Tax withholdingRestricted Shares (T) 150330 · Derivative | 980 | $26.42 Strike: $0.00 | $25,891.60 |
DisclosureSEC source: 0001415889-17-000554 · form4-03312017_020345.xml · derivative · entry 4 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,050 Underlying: Ordinary Shares · 9,030 shares Expires not disclosed F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F5 · shares: Represents shares withheld to cover payroll tax liability on vesting of previously granted restricted stock units. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 21:50 UTC | ARRIS International plc ARRS · Entity 158436 | Exercise / conversionOrdinary Shares | 2,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000554 · form4-03312017_020345.xml · nonDerivative · entry 1 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vested portion of a restricted stock unit grant converting to common stock. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 21:50 UTC | ARRIS International plc ARRS · Entity 158436 | GrantRestricted Shares (P) 170329 · Derivative | 26,220 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000554 · form4-03312017_020345.xml · derivative · entry 3 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,220 Underlying: Ordinary Shares · 26,220 shares Expires not disclosed F4 · security: Represents a restricted stock unit grant that is performance-based and can vest between 0 and 200% of the grant amount based on the Company's shareholder return as compared to the NASDAQ Composite shareholder return over a three-year measurement period. Amount shown reflects maximum vesting of the award at the 200% level. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 21:50 UTC | ARRIS International plc ARRS · Entity 158436 | GrantRestricted Shares (T) 170329 · Derivative | 13,110 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000554 · form4-03312017_020345.xml · derivative · entry 2 Macken Patrick W · CIK 0001641965 · SVP, GEN COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,110 Underlying: Ordinary Shares · 13,110 shares Expires not disclosed F2 · security: Represents a restricted stock unit grant that vests annually in fourths beginning one year from the date of the award. Date shown reflects the date upon which the award is fully vested. F3 · derivative.expiration_date: This restricted stock unit grant does not have a date of expiration, but will fully vest pursuant to the predetermined vesting schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.